{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:43:00Z","timestamp":1777444980341,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.det.2018.11.002","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T23:10:01Z","timestamp":1551827401000},"page":"137-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["What\u2019s New in Hair Loss"],"prefix":"10.1016","volume":"37","author":[{"given":"Leopoldo Duailibe Nogueira","family":"Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.det.2018.11.002_bib1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1001\/archderm.1994.01690060100013","article-title":"Postmenopausal frontal fibrosing alopecia. Scarring alopecia in a pattern distribution","volume":"130","author":"Kossard","year":"1994","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.11.002_bib2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jaad.2014.09.058","article-title":"Primary cicatricial alopecia: Lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia, and\u00a0Graham-Little syndrome","volume":"75","author":"Bolduc","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.11.002_bib3","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2013.12.003","article-title":"Frontal fibrosing alopecia: a multicenter review of 355 patients","volume":"70","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2018.11.002_bib4","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/jdv.14287","article-title":"Frontal fibrosing alopecia: clinical and prognostic classification","volume":"31","author":"Moreno-Arrones","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2018.11.002_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.12788\/j.sder.2015.0130","article-title":"Scarring alopecias: a trichologic emergency","volume":"34","author":"Siah","year":"2015","journal-title":"Semin Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.det.2018.11.002_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.det.2012.08.003","article-title":"Pattern hair loss in men: diagnosis and medical treatment","volume":"31","author":"Banka","year":"2013","journal-title":"Dermatol Clin"},{"issue":"3\u20134","key":"10.1016\/j.det.2018.11.002_bib7","first-page":"120","article-title":"Investigation of the plausibility of 5-alpha-reductase inhibitor syndrome","volume":"2","author":"Fertig","year":"2017","journal-title":"Skin Appendage Disord"},{"issue":"1","key":"10.1016\/j.det.2018.11.002_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","article-title":"Alopecia areata - an appraisal of new treatment approaches and overview of current therapies","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.11.002_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata - disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2018.11.002_bib10","first-page":"988","article-title":"Efficacy of isotretinoin and acitretin in treatment of frontal fibrosing alopecia: retrospective analysis of 54 cases","volume":"16","author":"Rakowska","year":"2017","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.det.2018.11.002_bib11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/jid.2008.369","article-title":"Hair follicle stem cell-specific PPARc deletion causes scarring alopecia","volume":"129","author":"Karnik","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.det.2018.11.002_bib12","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jaad.2013.04.066","article-title":"Lichen planopilaris treated by the peroxisome proliferator activated receptor-\u03b3 agonist pioglitazone: lack of lasting improvement or cure in the majority of patients","volume":"69","author":"Spring","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.11.002_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2310\/7750.2011.11008","article-title":"Use of pioglitazone in patients with lichen planopilaris","volume":"16","author":"Baibergenova","year":"2012","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"12","key":"10.1016\/j.det.2018.11.002_bib14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archdermatol.2009.283","article-title":"Lichen planopilaris treated with a peroxisome proliferator\u2013activated receptor \u03b3 agonist","volume":"145","author":"Mirmirani","year":"2009","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.11.002_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaad.2014.10.036","article-title":"The use of oral pioglitazone in the treatment of lichen planopilaris","volume":"72","author":"Mesinkovska","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.11.002_bib16","first-page":"731","article-title":"Short term 13-cis-retinoic acid treatment at therapeutic doses elevates expression of leptin, GLUT4, PPARgamma and aP2 in rat adipose tissue","volume":"59","author":"Krskova-Tybitanclova","year":"2008","journal-title":"J\u00a0Physiol Pharmacol"},{"issue":"1","key":"10.1016\/j.det.2018.11.002_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000477353","article-title":"A\u00a0review of platelet-rich plasma: history, biology, mechanism of action, and classification","volume":"4","author":"Alves","year":"2018","journal-title":"Skin Appendage Disord"},{"key":"10.1016\/j.det.2018.11.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.03.022","article-title":"Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy","author":"Ho","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2018.11.002_bib19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjd.12397","article-title":"A\u00a0randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata","volume":"169","author":"Trink","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.11.002_bib20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/dth.12343","article-title":"Platelet-rich plasma as a novel treatment for lichen planopillaris","volume":"29","author":"Bolan\u010da","year":"2016","journal-title":"Dermatol Ther"},{"issue":"12","key":"10.1016\/j.det.2018.11.002_bib21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/DSS.0000000000000901","article-title":"A\u00a0mechanistic model of platelet-rich plasma treatment for androgenetic alopecia","volume":"42","author":"Gupta","year":"2016","journal-title":"Dermatol Surg"},{"issue":"7","key":"10.1016\/j.det.2018.11.002_bib22","doi-asserted-by":"crossref","DOI":"10.5070\/D3247040910","article-title":"Platelet-rich plasma for androgenic alopecia treatment: a comprehensive review","volume":"24","author":"Girijala","year":"2018","journal-title":"Dermatol Online J"},{"issue":"5","key":"10.1016\/j.det.2018.11.002_bib23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/jocd.12679","article-title":"Systematic review of platelet-rich plasma (PRP) preparation and composition for the treatment of androgenetic alopecia","volume":"17","author":"Kramer","year":"2018","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.11.002_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.fsc.2018.06.008","article-title":"Platelet-rich plasma for hair loss: review of methods and results","volume":"26","author":"Badran","year":"2018","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"3","key":"10.1016\/j.det.2018.11.002_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/scrt218","article-title":"Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors","volume":"4","author":"Amable","year":"2013","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.det.2018.11.002_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/DSS.0000000000000665","article-title":"Randomized placebo-controlled, double-blind, half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia","volume":"42","author":"Alves","year":"2016","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2018.11.002_bib27","doi-asserted-by":"crossref","first-page":"760709","DOI":"10.1155\/2014\/760709","article-title":"The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation","volume":"2014","author":"Cervelli","year":"2014","journal-title":"Biomed Res Int"},{"issue":"11","key":"10.1016\/j.det.2018.11.002_bib28","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5966\/sctm.2015-0107","article-title":"The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial","volume":"4","author":"Gentile","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"10.1016\/j.det.2018.11.002_bib29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/14764172.2016.1225963","article-title":"Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: a pilot randomized controlled trial","volume":"18","author":"Mapar","year":"2016","journal-title":"J\u00a0Cosmet Laser Ther"},{"issue":"11","key":"10.1016\/j.det.2018.11.002_bib30","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/DSS.0000000000000883","article-title":"Double-blind, placebo-controlled pilot study on the use of platelet-rich plasma in women with female androgenetic alopecia","volume":"42","author":"Puig","year":"2016","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.det.2018.11.002_bib31","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4103\/idoj.IDOJ_11_17","article-title":"Platelet-rich plasma by single spin process in male pattern androgenetic alopecia: is it an effective treatment?","volume":"8","author":"Ayatollahi","year":"2017","journal-title":"Indian Dermatol Online J"},{"issue":"9","key":"10.1016\/j.det.2018.11.002_bib32","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/DSS.0000000000001567","article-title":"Evaluating the efficacy of different platelet-rich plasma regimens for management of androgenetic alopecia: a single-center, blinded, randomized clinical trial","volume":"44","author":"Hausauer","year":"2018","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.det.2018.11.002_bib33","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz","year":"2015","journal-title":"Nat Commun"},{"issue":"7302","key":"10.1016\/j.det.2018.11.002_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova","year":"2010","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.det.2018.11.002_bib35","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nm.3685","article-title":"Inhibiting Janus kinases to treat alopecia areata","volume":"20","author":"Divito","year":"2014","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.det.2018.11.002_bib36","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.det.2018.11.002_bib37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.det.2018.11.002_bib38","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.jid.2018.05.027","article-title":"JAK inhibitors for treatment of alopecia areata","volume":"138","author":"Wang","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"7","key":"10.1016\/j.det.2018.11.002_bib39","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jid.2018.01.032","article-title":"An open-label pilot study to evaluate the efficacy of tofacitinib in moderate to severe patch-type alopecia areata, totalis, and universalis","volume":"138","author":"Jabbari","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.11.002_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaad.2016.09.007","article-title":"Tofacitinib for the treatment of severe alopecia areata and variants: a study of 90 patients","volume":"76","author":"Liu","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.11.002_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2016.09.006","article-title":"Tofacitinib for the treatment of alopecia areata and variants in adolescents","volume":"76","author":"Craiglow","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"15","key":"10.1016\/j.det.2018.11.002_bib42","doi-asserted-by":"crossref","first-page":"e89776","DOI":"10.1172\/jci.insight.89776","article-title":"Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata","volume":"1","author":"Kennedy Crispin","year":"2016","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.det.2018.11.002_bib43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaad.2017.03.024","article-title":"Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata","volume":"77","author":"Bayart","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.11.002_bib44","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamadermatol.2015.4445","article-title":"Topical ruxolitinib for the treatment of alopecia universalis","volume":"152","author":"Craiglow","year":"2016","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.11.002_bib45","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/1203475417716363","article-title":"A\u00a0case of topical ruxolitinib treatment failure in alopecia areata","volume":"21","author":"Deeb","year":"2017","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"12","key":"10.1016\/j.det.2018.11.002_bib46","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/ijd.14192","article-title":"Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study","volume":"57","author":"Bokhari","year":"2018","journal-title":"Int J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863518311409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863518311409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T01:17:22Z","timestamp":1663031842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863518311409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0733863518311409"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2018.11.002","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What\u2019s New in Hair Loss","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2018.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}